Cowen_Logo_rgb_k.jpg
Cowen Announces Closing of Underwriters’ Exercise of Over-Allotment Option to Purchase an Additional $10.0 Million of 7.75% Senior Notes Due 2033
June 18, 2018 16:01 ET | Cowen Inc.
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (the “Company”) announced today the underwriters for the recently completed public offering of the Company’s 7.75% senior notes...
Cowen_Logo_rgb_k.jpg
Cowen Inc. Announces Closing of Public Offering of 7.75% Senior Notes Due 2033
June 11, 2018 16:01 ET | Cowen Inc.
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (the “Company”) announced today that its previously announced public offering of $90,000,000 million of 7.75% senior notes due...
Optinose_logo_RGB.png
Optinose Announces Launch of Public Offering of Common Stock
June 04, 2018 16:56 ET | OptiNose, Inc.
YARDLEY, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission...
New logo.png
Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
May 14, 2018 16:26 ET | Amedica Corporation
SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
CocrystalPharmaInc.jpg
Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update
May 11, 2018 08:00 ET | Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, May 11, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Closing Of Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares
May 07, 2018 11:47 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 07, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leading gene therapy company advancing transformative therapies for patients with...
Check-Cap Announces
Check-Cap Announces Pricing of $17.5 Million Upsized Underwritten Public Offering
May 04, 2018 09:15 ET | Check-Cap Ltd.
ISFIYA, Israel, May 04, 2018 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical-stage medical diagnostics company engaged in the development...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Pricing of its Public Offering
May 02, 2018 19:32 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 02, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leading gene therapy company advancing transformative therapies for patients with...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Proposed Public Offering
May 01, 2018 16:04 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 01, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leading gene therapy company advancing transformative therapies for patients with...
MTBC logo
MTBC to Announce Q1 2018 Financial Results and Host Conference Call on May 15, 2018
April 16, 2018 09:00 ET | MTBC
SOMERSET, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- MTBC (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, will release its...